perimenopause and tirzepatide vs Semaglutide Safety: What Perimenopausal Women Need to Know Here is my 1-year GLP-1

The SURMOUNT clinical trial program, which evaluated tirzepatide for weight management, showed improvements in multiple cardiometabolic risk factors, including lipid parameters

The FDA website can be found here

## Morning Dosing: Why It Works Best for Most People **The sweet spot is 7 to 10 AM.** Taking NAD+ during this window aligns with your natural circadian rise, supports the daytime energy peak, enhances cognitive function during your most productive hours, and is least likely to interfere with sleep

Because the results depend heavily on the exact treatment settings (waveform, intensity, frequency, and duration), it is important for clinicians to carefully document the treatment plan and base recommendations on high-quality research whenever possible